sodium-glucose co-transporter 2(English)
- while originally developed to manage hyperglycemia in people with T2DM, they have consistently been found to improve heart failure and kidney outcomes. Also denoted as SGLT-2
- QRISC2, HHF, MI, CVM, HF, GLP-1RA, MACE, SGLT2, T2DM, T2DM, HF, CVD, MACE, ACM
- Cardiology, Therapeutic approaches, Sodium, Kidney and adrenals
- https://doi.org…NAHA.120.051122
- https://doi.org…rheartj/ehaa530
- https://doi.org….1111/dme.14922
- https://doi.org…al.pone.0244689